Dual Mechanisms of Metabolism and Gene Expression of the CCRF-CEM Leukemia Cells Under Glucocorticoid Treatment

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2021 Jun 2

PMID 34072627

Citations 1

Authors

George I Lambrou

Theodoros Karakonstantakis

Spiros Vlahopoulos

Apostolos Zaravinos

Affiliations

Soon will be listed here.

Abstract

Background: Glucocorticoids play an essential part in anti-leukemic therapies, but resistance is a crucial event for the prognosis of the disease. Glucocorticoids influence the metabolic properties of leukemic cells. The inherent plasticity of clinically evolving cancer cells justifies the characterization of drug-induced early oncogenic pathways, which represent a likely source of detrimental secondary effects.

Aim: The present work aims to investigate the effect of glucocorticoids in metabolic pathways in the CCRF-CEM leukemic cells. Metabolic factors and gene expression profiles were examined in order to unravel the possible mechanisms of the CCRF-CEM leukemic cell growth dynamics.

Methods: CCRF-CEM cells were used as a model. Cells were treated with prednisolone with concentrations 0-700 μM. Cell culture supernatants were used for glucose, lactic acid, LDH, Na, K and Ca measurements. Cytotoxicity was determined with flow cytometry. Microarray analysis was performed using two different chips of 1.2 k and 4.8 k genes. Gene Ontology enrichment analysis was applied to find metabolism- and GC-related genes.

Results: Higher prednisolone concentrations inhibited glucose uptake, without exhibiting any cytotoxic effects. Glucose consumption did not correlate with the total cell population, or the viable population, indicating that growth is not directly proportional to glucose consumption. Neither of the subpopulations, i.e., viable, necrotic, or apoptotic cells, contributed to this.

Conclusions: Different types of leukemic cells seem to exhibit different patterns of glucose metabolism. Both resistant and sensitive CCRF-CEM cells followed the aerobic pathway of glycolysis. There is probably a rapid change in membrane permeability, causing a general shutdown towards everything that is outside the cell. This could in part also explain the observed resistance. Glucocorticoids do not enter the cell passively anymore and therefore no effects are observed. Based on our observations, ion concentrations are measurable factors both in vitro and in vivo, which makes them possible markers of glucocorticoid cytotoxic action.

Citing Articles

Riding the Wave of Ambivalence in Cell Biology.

Emanuele S, Giuliano M Int J Mol Sci. 2024; 25(13).

PMID: 39000455 PMC: 11242416. DOI: 10.3390/ijms25137348.

References

Thompson E, Johnson B . Regulation of a distinctive set of genes in glucocorticoid-evoked apoptosis in CEM human lymphoid cells. Recent Prog Horm Res. 2003; 58:175-97. DOI: 10.1210/rp.58.1.175. View

Lang F, Singh Y, Salker M, Ma K, Pandyra A, Lang P . Glucose transport in lymphocytes. Pflugers Arch. 2020; 472(9):1401-1406. DOI: 10.1007/s00424-020-02416-y. View

Bhowmick N, Neilson E, Moses H . Stromal fibroblasts in cancer initiation and progression. Nature. 2004; 432(7015):332-7. PMC: 3050735. DOI: 10.1038/nature03096. View

Zhang B, Schmoyer D, Kirov S, Snoddy J . GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies. BMC Bioinformatics. 2004; 5:16. PMC: 373441. DOI: 10.1186/1471-2105-5-16. View

Ormerod M, Payne A, Watson J . Improved program for the analysis of DNA histograms. Cytometry. 1987; 8(6):637-41. DOI: 10.1002/cyto.990080617. View

Verma D, Kantarjian H, Jones D, Luthra R, Borthakur G, Verstovsek S . Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of characteristics, outcomes, and prognostic significance. Blood. 2009; 114(11):2232-5. PMC: 4828071. DOI: 10.1182/blood-2009-02-204693. View

Berczi I . Pituitary hormones and immune function. Acta Paediatr Suppl. 1997; 423:70-5. DOI: 10.1111/j.1651-2227.1997.tb18376.x. View

Griner E, Kazanietz M . Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer. 2007; 7(4):281-94. DOI: 10.1038/nrc2110. View

Song M, Chung J, Seol Y, Kim S, Shin H, Choi Y . Mean cell volume can be an early predictor for the cytogenetic response of chronic myeloid leukemia patients treated with imatinib?. Leuk Res. 2009; 33(11):1459-62. DOI: 10.1016/j.leukres.2009.04.017. View

10.

Miyazato A, Ueno S, Ohmine K, Ueda M, Yoshida K, Yamashita Y . Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction. Blood. 2001; 98(2):422-7. DOI: 10.1182/blood.v98.2.422. View

11.

Jackson R, Liebich M, Berry P, Errington J, Liu J, Parker C . Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia-a report from the UKALL 2011 trial. Eur J Cancer. 2019; 120:75-85. DOI: 10.1016/j.ejca.2019.07.026. View

12.

Tiefenthaler M, Amberger A, Bacher N, Hartmann B, Margreiter R, Kofler R . Increased lactate production follows loss of mitochondrial membrane potential during apoptosis of human leukaemia cells. Br J Haematol. 2001; 114(3):574-80. DOI: 10.1046/j.1365-2141.2001.02988.x. View

13.

Araujo E, Carvalheira J, Velloso L . Disruption of metabolic pathways--perspectives for the treatment of cancer. Curr Cancer Drug Targets. 2006; 6(1):77-87. DOI: 10.2174/156800906775471734. View

14.

Tonko M, Ausserlechner M, Bernhard D, Helmberg A, Kofler R . Gene expression profiles of proliferating vs. G1/G0 arrested human leukemia cells suggest a mechanism for glucocorticoid-induced apoptosis. FASEB J. 2001; 15(3):693-9. DOI: 10.1096/fj.00-0327com. View

15.

Ogretmen B . Sphingolipids in cancer: regulation of pathogenesis and therapy. FEBS Lett. 2006; 580(23):5467-76. DOI: 10.1016/j.febslet.2006.08.052. View

16.

Dussiau C, Trinquand A, Lhermitte L, Latiri M, Simonin M, Cieslak A . Targeting IRAK1 in T-cell acute lymphoblastic leukemia. Oncotarget. 2015; 6(22):18956-65. PMC: 4662467. DOI: 10.18632/oncotarget.4150. View

17.

Pollak N, Dolle C, Ziegler M . The power to reduce: pyridine nucleotides--small molecules with a multitude of functions. Biochem J. 2007; 402(2):205-18. PMC: 1798440. DOI: 10.1042/BJ20061638. View

18.

Daynes R, Araneo B . Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur J Immunol. 1989; 19(12):2319-25. DOI: 10.1002/eji.1830191221. View

19.

Schiavon V, Duchez S, Branchtein M, How-Kit A, Cassius C, Daunay A . Microenvironment tailors nTreg structure and function. Proc Natl Acad Sci U S A. 2019; 116(13):6298-6307. PMC: 6442590. DOI: 10.1073/pnas.1812471116. View

20.

Gatenby R, Gillies R . Why do cancers have high aerobic glycolysis?. Nat Rev Cancer. 2004; 4(11):891-9. DOI: 10.1038/nrc1478. View